PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
07-Feb-2020 Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that Rubraca® (rucaparib) is now available and reimbursed in France. Clovis Oncology, Inc
07-Feb-2020 CapsCanada's Empty Capsules and Supply Chain Unaffected by the Coronavirus Outbreak CapsCanada
07-Feb-2020 Mediclinic Southern Africa announces approval for the acquisition of Matlosana hospitals Mediclinic International
07-Feb-2020 Advanced Therapies Apprenticeship Community roadshow showcases value of apprenticeships for upskilling in the advanced therapies industry Cell and Gene Therapy Catapult
07-Feb-2020 Freeline presents data on AAV-based gene therapies for Haemophilia B at EAHAD Freeline
07-Feb-2020 Inceptua and Portola enter exclusive distribution agreement for Ondexxya® Inceptua
07-Feb-2020 Freeline publishes further data for FLT180a Syncona Ltd
07-Feb-2020 Valo Therapeutics Announces New Funding for Immuno-Oncology Trials Valo Therapeutics
07-Feb-2020 Almac Group launches enhanced Label Approval Solution (LAS) Almac Group
07-Feb-2020 Chi-Med Announces the Exercise of Underwriters’ Over-allotment Option for Public Offering of ADSs Chi-Med
07-Feb-2020 Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis Sanofi
07-Feb-2020 PharmaLex expands compliance service offerings PharmaLex
07-Feb-2020 Khondrion appoints Rob van Maanen as Chief Medical Officer Khondrion
07-Feb-2020 CARMAT announces FDA full approval to initiate US clinical feasibility study of its total artificial heart CARMAT
07-Feb-2020 Major investment to transform UK’s leading cancer campus The Institute of Cancer Research
07-Feb-2020 Janssen announces European licence extension for Erleada®▼ (apalutamide) for patients with metastatic hormone-sensitive prostate cancer The Janssen Pharmaceutical Companies of Johnson & Johnson
07-Feb-2020 ALTAIR study confirms the effectiveness of Bayer’s aflibercept (EYLEA®) with Treat and Extend dosing regimens in wet AMD Bayer
07-Feb-2020 Oxurion NV – Additional Topline Data from Positive Phase 1 Trial with THR-687 in Patients with Diabetic Macular Edema (DME) to be Presented at the Upcoming Angiogenesis, Exudation, and Degeneration 2020 Conference Oxurion
07-Feb-2020 Synteract Expands into Asia Pacific and South Africa Through Acquisition of Specialty Biometrics CRO Synteract
07-Feb-2020 Resolution of Cyber Security Incident Tissue Regenix Group